Blood Pressure Lowering Effect Of Hypertension Treatment Device Further Validated In New Studies

European Society of Hypertension — Booth # 21, Hall 15.1 — InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), announced the findings of new studies and analysis highlighting RESPeRATE — the only medical device cleared by the FDA and CE-approved for the treatment of hypertension. Five posters will be presented at the European Society of Hypertension meeting (ESH) in Berlin beginning June 14, 2008.

More: continued here

Filed under: Hypertension on June 19th, 2008